LON:CRW - Craneware Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started GBX 3,090 -10.00 (-0.32 %) (As of 05/26/2019 07:47 AM ET)Previous CloseGBX 3,090Today's RangeGBX 3,060 - GBX 3,13952-Week RangeGBX 1,615 - GBX 3,650Volume9,386 shsAverage Volume14,260 shsMarket Capitalization£813.55 millionP/E Ratio49.76Dividend Yield0.94%BetaN/A ProfileAnalyst RatingsChartDividendInsider TradesHeadlines Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Craneware plc, together with its subsidiaries, develops, licenses, and supports computer software for the healthcare industry in the United States. The company offers patient engagement solutions, such as InSight Medical Necessity, a software-as-a-service (SaaS) solution that provides medical necessity validation for United States payers and advance beneficiary notice creation; and Trisus Patient Payment, which provides hospitals and health systems to modernize patient payment. It also provides charge capture and pricing solutions, such as Chargemaster Toolkit, Chargemaster Toolkit Discovery Viewer, and Chargemaster Toolkit Corporate Discovery Viewer for capturing optimal legitimate reimbursement for providers; Physician Revenue Toolkit, a SaaS solution for managing physician group KPIs, charges, codes, RVUs, fee schedules, and related information; Pricing Analyzer, a SaaS solution that simplifies the price modelling process; Reference Plus, a SaaS solution to perform Chargemaster analysis; Pharmacy ChargeLink, a solution to enhance charge capture, pricing, and cost management; Trisus Supply, a solution that utilizes data to identify data gaps between the systems; and supporting modules, including Online Reference Toolkit, interface scripting module, and supplies assistant. In addition, the company provides Trisus Claims Informatics, a software that automates claim and coding reviews; InSight Audit, a Web-based audit management tool for healthcare organizations to manage government and commercial audits; and InSight Denials to analyze, track, trend, and report on denial data. Further, it provides Trisus Healthcare Intelligence, a cost analytics and resource efficiency platform; consulting and professional services; and sales and marketing, product development, and software development services. Craneware plc was founded in 1999 and is headquartered in Edinburgh, the United Kingdom. Receive CRW News and Ratings via Email Sign-up to receive the latest news and ratings for CRW and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange LON Industry Health Information Services Sub-IndustryN/A SectorComputer and Technology Current SymbolLON:CRW Previous Symbol CUSIPN/A CIKN/A Webhttp://public.craneware.com/ Phone+44-131-5503100Debt Debt-to-Equity RatioN/A Current Ratio1.46 Quick Ratio1.40Price-To-Earnings Trailing P/E Ratio49.76 Forward P/E Ratio38.15 P/E GrowthN/A Sales & Book Value Annual Sales£71.78 million Price / Sales11.33 Cash FlowGBX 160.97 per share Price / Cash Flow19.20 Book ValueGBX 213.70 per share Price / Book14.46Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous Employees320 Outstanding Shares26,328,500Market Cap£813.55 million Next Earnings DateN/A OptionableNot Optionable Craneware (LON:CRW) Frequently Asked Questions What is Craneware's stock symbol? Craneware trades on the London Stock Exchange (LON) under the ticker symbol "CRW." How often does Craneware pay dividends? What is the dividend yield for Craneware? Craneware announced a dividend on Tuesday, March 5th. Investors of record on Thursday, March 14th will be given a dividend of GBX 11 per share on Thursday, April 11th. This represents a dividend yield of 0.42%. The ex-dividend date is Thursday, March 14th. The official announcement can be viewed at this link. View Craneware's Dividend History. What price target have analysts set for CRW? 2 Wall Street analysts have issued 12-month price objectives for Craneware's shares. Their predictions range from GBX 3,505 to GBX 3,600. On average, they expect Craneware's share price to reach GBX 3,552.50 in the next year. This suggests a possible upside of 15.0% from the stock's current price. View Analyst Price Targets for Craneware. What is the consensus analysts' recommendation for Craneware? 2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Craneware in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Craneware. Has Craneware been receiving favorable news coverage? News headlines about CRW stock have been trending negative recently, InfoTrie Sentiment Analysis reports. InfoTrie rates the sentiment of news coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. Craneware earned a news sentiment score of -2.0 on InfoTrie's scale. They also assigned media headlines about the company a news buzz of 8.0 out of 10, meaning that recent news coverage is very likely to have an effect on the company's share price in the next several days. Who are some of Craneware's key competitors? Some companies that are related to Craneware include Compugroup Medical (COP), Pro Medicus (PME), Sensyne Health (SENS), Kneat.com (KSI), Medadvisor (MDR), Alcidion Group (ALC), Mach7 Technologies (M7T), Vitalhub (VHI), CogState (CGS), Reliq Health Technologies (RHT), Oneview Healthcare (ONE), Diagnos (ADK), ICSGlobal (ICS), CardioComm Solutions (EKG) and Novita Healthcare (NHL). What other stocks do shareholders of Craneware own? Based on aggregate information from My MarketBeat watchlists, some companies that other Craneware investors own include Accesso Technology Group (ACSO), Telford Homes (TEF), Albert Technologies (ALB), Ashtead Group (AHT), Allergy Therapeutics (AGY), Alpha Financial Markets Consulting (AFM), Active Energy Group (AEG), Adept Technology Group (ADT), ACM Shipping Group (ACMG) and Abcam (ABC). Who are Craneware's key executives? Craneware's management team includes the folowing people: Mr. Keith Neilson, Co-Founder, CEO & Exec. Director (Age 50)Mr. Craig Thomas Preston, CFO, Company Sec. & Exec. Director (Age 48)Mr. Marty Smith, Chief Technology OfficerMr. Derek W. Paterson, Chief Information OfficerSeth Droe, Exec. VP of Sales How do I buy shares of Craneware? Shares of CRW and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. What is Craneware's stock price today? One share of CRW stock can currently be purchased for approximately GBX 3,090. How big of a company is Craneware? Craneware has a market capitalization of £813.55 million and generates £71.78 million in revenue each year. Craneware employs 320 workers across the globe. What is Craneware's official website? The official website for Craneware is http://public.craneware.com/. How can I contact Craneware? Craneware's mailing address is 1 Tanfield, EDINBURGH, EH3 5DA, United Kingdom. The company can be reached via phone at +44-131-5503100. MarketBeat Community Rating for Craneware (LON CRW)Community Ranking: 2.6 out of 5 ( )Outperform Votes: 191 (Vote Outperform)Underperform Votes: 175 (Vote Underperform)Total Votes: 366MarketBeat's community ratings are surveys of what our community members think about Craneware and other stocks. Vote "Outperform" if you believe CRW will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CRW will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 5/26/2019 by MarketBeat.com StaffFeatured Article: Balance Sheet Receive Analysts' Upgrades and Downgrades Daily Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.